HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
equine infectious anemia virus SU protein
amino acid sequence given in first source; GenBank M16575
Also Known As:
SU protein, equine infectious anemia virus; EIAV gp90; env gp90, EIAV; glycoprotein 90, equine infectious anemia virus; surface unit protein, EIAV
Networked:
6
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Glycoconjugates: 1353
Glycoproteins: 24834
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
equine infectious anemia virus SU protein: 6
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Glycoproteins: 24834
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
equine infectious anemia virus SU protein: 6
Membrane Proteins: 10078
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
equine infectious anemia virus SU protein: 6
Viral Proteins: 4250
Viral Structural Proteins: 171
Viral Envelope Proteins: 291
equine infectious anemia virus SU protein: 6
Experts
1.
Cascio, Michael
: 1 article (02/2008)
2.
Jin, Sha
: 1 article (02/2008)
3.
Montelaro, Ronald C
: 1 article (02/2008)
4.
Sun, Chengqun
: 1 article (02/2008)
5.
Zhang, Baoshan
: 1 article (02/2008)
Related Diseases
1.
Infections
01/01/1990 - "
Specific IgG to EIAV gp90, gp45, and p26 of homologous and heterologous isolates was detectable by immunoblots within one month after infection although IgG levels to gp45 at this time were relatively low.
"
02/01/1992 - "
The arrangement of neutralizing epitopes and critical structural considerations suggest that EIAV gp90 contains a principal neutralizing domain similar to the V3 loop of human immunodeficiency virus type 1. These antigenic analyses provide an important foundation for further analyzing the protective immune response generated during persistent EIAV infections and also provide potential peptide substrates for diagnostic assays and for vaccine strategies.
"
07/30/1984 - "
The immunogenic contributions of the carbohydrate and peptide portions of the major envelope glycoprotein of equine infections anemia virus, EIAV gp90, were analyzed by measuring the effects of specific glycosidase and protease digestions on the reactivity of the glycoprotein with immune sera from infected horses.
"
2.
Lentivirus Infections
02/15/1994 - "
Thus, the recombinant EIAV gp90 vaccine provides a novel in vivo model for examining in detail the mechanisms of immune enhancement of a lentivirus infection and for evaluating strategies to avoid the production of deleterious immune responses in AIDS vaccine design.
"
3.
Virus Diseases (Viral Diseases)
02/01/2008 - "
Mutations of individual amino acids in the CRD1 segment of ELR1 and murine HveA indicated the Leu70 in CRD1 as essential for functional binding of EIAV gp90 and for virus infection of transduced Cf2Th cells.
"
4.
Anemia
07/30/1984 - "
The immunogenic contributions of the carbohydrate and peptide portions of the major envelope glycoprotein of equine infections anemia virus, EIAV gp90, were analyzed by measuring the effects of specific glycosidase and protease digestions on the reactivity of the glycoprotein with immune sera from infected horses.
"
5.
Acquired Immunodeficiency Syndrome (AIDS)
07/01/1988 - "
The RIP and RIA analyses demonstrated that HIV gp120 is equally reactive with the AIDS patient serum, the goat anti-gp120 serum and the EIAV-infected horse serum, whereas the EIAV gp90 reacted only with the horse serum.
"
07/01/1988 - "
The reported serological relatedness between the major glycoproteins of human immunodeficiency virus (HIV gp120) and equine infectious anaemia virus (EIAV gp90) was examined using purified antigens in radioimmunoprecipitation (RIP), radioimmunoassay (RIA) and immunoblot assays with reference serum from acquired immunodeficiency syndrome (AIDS) patients, an anti-gp120 goat serum and EIAV-infected horse serum.
"
Related Drugs and Biologics
1.
Vaccines
2.
Peptides (Polypeptides)
3.
Glycoproteins (Glycoprotein)
4.
AIDS Vaccines
5.
Peptide Hydrolases (Proteases)
6.
Immune Sera (Antisera)
7.
Immunoglobulin G (IgG)
8.
Glycoside Hydrolases (Endoglycosidases)
9.
Carbohydrates
10.
Antigens